CLINICAL_TRIALS
trial_result
· 2022-09-10
Clinical Trial Update: SGLT2 Inhibitors in Patients With PCOS [Phase 4]
Summary
Phase 4 clinical trial update evaluating SGLT2 inhibitors in patients with polycystic ovary syndrome has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Shanghai 10th People's Hospital | Conditions: Polycystic Ovary Syndrome | Phase 4 | Status: COMPLETED